← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
GE HealthCare grew revenue 4.8% to $20.63B and net income 4.6% to $2.08B, while tariffs and cost inflation took 172 bps off gross margin and it began buying back stock
The read at a glance✓ Audited against SEC data
- Growth — Revenue up 4.8% to $20.63B; 3.5% organicOK
- Profitability — Operating margin flat at 13.4%; gross margin down 172 bpsWatch
- Balance sheet — Debt $10,003 million; $2,300 million Intelerad deal pendingNote
- Accounting quality — Grey-zone balance-sheet screen; no manipulation flag; clean auditNote
- Capital allocation — First buybacks, $0.20B; dividends $0.06BNote
- Order book — Remaining performance obligations $15,729 million, up from $14,491 millionOK
Business
GE HealthCare, spun off from General Electric on January 3, 2023, sells medical imaging equipment, ultrasound, patient monitors and anesthesia machines, and the contrast and radiopharmaceutical agents injected during scans, then services the installed base for years. Services were $6,964 million of 2025 revenue and remaining performance obligations for services stood at $10,728 million, which gives the company a recurring layer under a cyclical equipment business.
Where the revenue comes from
Fiscal 2025, as GE HealthCare Technologies Inc. reports it. History and quarterly detail are in the app.
- Imaging$9.2B
- AVS$5.4B
- PCS$3.1B
- PDx$2.9B
Leadership changes
From GE HealthCare Technologies Inc.'s own filings, the day they're filed.
- Kevin A. Lobo · director · appointmenteff. 2026-03-13
- Risa Lavizzo-Mourey · departureeff. 2026-03-13
- Tomislav Mihaljevic · departureeff. 2026-03-13
Latest filings
- 8-K · Company announcement2026-09-22
- 8-K · Company announcement2026-08-18
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-07-29
- 8-K · Company announcement2026-07-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about GE HealthCare Technologies Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.